Bijoy Hans Limited to become Arvaya Healthcare Limited as Board Greenlights ₹200 Cr Financial Expansion

Bijoy Hans Limited's Board has approved significant corporate actions, including a name change to Arvaya Healthcare Limited and an increase in borrowing limits and authorized share capital to ₹200 crore.

The company is also exploring a technology platform development with GTT Data Solutions Limited, valued up to ₹5 crore.

Reader Takeaway: Healthcare pivot and ₹200 Cr financial muscle signal growth; regulatory hurdles and LOI execution remain key watchpoints.

What just happened (today’s filing)

Bijoy Hans Limited announced on March 17, 2026, that its Board of Directors has given the green light for a strategic name change to 'Arvaya Healthcare Limited'.

This rebranding aims to better align with the company's evolving business focus and healthcare aspirations.

The Board also sanctioned a substantial hike in the company's borrowing capacity, authorizing limits up to ₹200 crore under Section 180(1)(c) of the Companies Act, 2013.

Furthermore, the authorized share capital is set to increase to ₹200 crore, alongside approving limits for loans, guarantees, and investments up to ₹200 crore under Section 186.

A non-binding Letter of Intent was noted for developing a technology platform with GTT Data Solutions Limited, with a valuation of up to ₹5 crore.

Why this matters

The proposed name change to 'Arvaya Healthcare Limited' signifies a clear strategic shift towards the healthcare sector, potentially unlocking new growth avenues and investor interest.

The significant increase in borrowing limits and authorized capital provides the company with enhanced financial flexibility for future expansion, acquisitions, or working capital needs.

The exploration of a technology platform development with GTT Data Solutions points towards potential digital transformation or innovation initiatives within its healthcare focus.

The backstory (grounded)

Bijoy Hans Limited, established in 1985, has historically traded in pharmaceutical, medical, and cosmetic goods, and engaged in investment activities [1, 2, 14]. The company has faced challenges, including financial underperformance and a past SEBI warning for delayed fee filings [7, 11].

Recently, the company has been active in capital raising and strategic realignments. It had previously approved a name change to 'Arvaya Healthtech Limited' but withdrew it on March 11, 2026, opting for the more healthcare-centric 'Arvaya Healthcare Limited' due to revised strategies [6, 8, 15, 16].

Bijoy Hans has also been involved in acquiring healthcare entities, such as Health Secure Hospitals and Arvaya Health and Wellness, through share swaps, signaling a concrete pivot into the sector [13]. GTT Data Solutions, the potential partner for the technology platform, is a player in AI, machine learning, and cloud computing, focused on data analytics solutions [1, 3, 5].

What changes now

Upon obtaining necessary approvals, the company will officially operate under the new name 'Arvaya Healthcare Limited'.

Shareholders will witness a substantial increase in the company's financial leverage capacity, enabling more aggressive strategic moves.

The exploration of a technology partnership could lead to enhanced digital offerings or operational efficiencies within the healthcare domain.

This rebranding aligns the company's identity with its apparent strategic direction towards healthcare services and technologies.

Risks to watch

All major decisions, including the name change, borrowing limit increase, and share capital raise, are subject to requisite regulatory and shareholder approvals, which may cause delays or modifications.

The Letter of Intent with GTT Data Solutions is non-binding and contingent on satisfactory due diligence, valuation, and definitive agreement finalization.

The company's historical financial performance may pose a challenge to investor confidence, necessitating a strong turnaround and execution post-strategic shift.

Peer comparison

Companies like Arvaya Health & Wellness, which focuses on an integrated health ecosystem, share a similar brand name and sector focus, indicating a potential strategic alignment or ambition in the healthcare space [21].

Larger players such as Fortis Healthcare Ltd. and Apollo Hospitals Enterprise Ltd. represent the established benchmarks in India's healthcare services sector, showcasing the scale and scope attainable in this industry [Fortis Healthcare, Apollo Hospitals].

Bijoy Hans's pivot aims to leverage technology and strategic capital infusion to establish a presence in this competitive and growing sector.

Context metrics (time-bound)

• As of March 17, 2026, Bijoy Hans Limited's authorized share capital is proposed to be increased to ₹200 crore.
• Borrowing limits under Section 180(1)(c) are proposed to be increased to ₹200 crore as of March 17, 2026.
• The non-binding LOI for technology platform development with GTT Data Solutions is valued up to ₹5 crore.

What to track next

Shareholder approval for the proposed name change, borrowing limits, and authorized share capital increase via postal ballot is a critical next step.

Investors will monitor the finalization of definitive agreements for the technology platform development with GTT Data Solutions.

Securing all necessary regulatory and statutory approvals for the corporate rebranding will be essential for its effective implementation.

The company's ability to execute its new healthcare strategy and leverage its expanded financial capacity will be key indicators for future performance.